论文部分内容阅读
2011年2月,美国感染性疾病协会发布了第一个在循证基础上制定的成人与儿童耐甲氧西林金黄色葡萄球菌(MRSA)感染治疗的临床实践指南,指南就MRSA感染相关的一系列临床综合征包括皮肤软组织感染、菌血症和心内膜炎、肺炎、骨关节感染及中枢神经系统感染的治疗展开讨论,并推荐万古霉素的剂量和监测方法,对万古霉素敏感性降低的MRSA菌株及万古霉素治疗失败病例的管理。现选取该指南中与儿童有关的内容介绍如下。
In February 2011, the Infectious Diseases Society of the United States published the first clinical practice guideline for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in adults and children based on evidence-based guidelines that guide one A series of clinical syndromes including skin and soft tissue infections, bacteremia and endocarditis, pneumonia, osteoarthritis and central nervous system infections were discussed and recommended vancomycin doses and monitoring methods for vancomycin sensitivity Reduced management of MRSA strains and vancomycin-treated failure cases. Now select the children-related content of the guide are as follows.